These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37854018)

  • 21. Understanding response and resistance to oestrogen deprivation in ER-positive breast cancer.
    Patani N; Martin LA
    Mol Cell Endocrinol; 2014 Jan; 382(1):683-694. PubMed ID: 24121024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CDK11p58 inhibits ERα-positive breast cancer invasion by targeting integrin β3 via the repression of ERα signaling.
    Chi Y; Huang S; Wang L; Zhou R; Wang L; Xiao X; Li D; Cai Y; Zhou X; Wu J
    BMC Cancer; 2014 Aug; 14():577. PubMed ID: 25106495
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AKT3 regulates ErbB2, ErbB3 and estrogen receptor α expression and contributes to endocrine therapy resistance of ErbB2(+) breast tumor cells from Balb-neuT mice.
    Grabinski N; Möllmann K; Milde-Langosch K; Müller V; Schumacher U; Brandt B; Pantel K; Jücker M
    Cell Signal; 2014 May; 26(5):1021-9. PubMed ID: 24463007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protein Kinase A-induced tamoxifen resistance is mediated by anchoring protein AKAP13.
    Bentin Toaldo C; Alexi X; Beelen K; Kok M; Hauptmann M; Jansen M; Berns E; Neefjes J; Linn S; Michalides R; Zwart W
    BMC Cancer; 2015 Aug; 15():588. PubMed ID: 26272591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic value of estrogen receptor α and progesterone receptor conversion in distant breast cancer metastases.
    Hoefnagel LD; Moelans CB; Meijer SL; van Slooten HJ; Wesseling P; Wesseling J; Westenend PJ; Bart J; Seldenrijk CA; Nagtegaal ID; Oudejans J; van der Valk P; van Gils CH; van der Wall E; van Diest PJ
    Cancer; 2012 Oct; 118(20):4929-35. PubMed ID: 22415862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. STAT1 facilitates oestrogen receptor α transcription and stimulates breast cancer cell proliferation.
    Hou Y; Li X; Li Q; Xu J; Yang H; Xue M; Niu G; Zhuo S; Mu K; Wu G; Li X; Wang H; Zhu J; Zhuang T
    J Cell Mol Med; 2018 Dec; 22(12):6077-6086. PubMed ID: 30334368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heat shock factor 1 (HSF1) cooperates with estrogen receptor α (ERα) in the regulation of estrogen action in breast cancer cells.
    Vydra N; Janus P; Kus P; Stokowy T; Mrowiec K; Toma-Jonik A; Krzywon A; Cortez AJ; Wojtas B; Gielniewski B; Jaksik R; Kimmel M; Widlak W
    Elife; 2021 Nov; 10():. PubMed ID: 34783649
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumour necrosis factor and PI3-kinase control oestrogen receptor alpha protein level and its transrepression function.
    Bhat-Nakshatri P; Campbell RA; Patel NM; Newton TR; King AJ; Marshall MS; Ali S; Nakshatri H
    Br J Cancer; 2004 Feb; 90(4):853-9. PubMed ID: 14970864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevated collagen-I augments tumor progressive signals, intravasation and metastasis of prolactin-induced estrogen receptor alpha positive mammary tumor cells.
    Barcus CE; O'Leary KA; Brockman JL; Rugowski DE; Liu Y; Garcia N; Yu M; Keely PJ; Eliceiri KW; Schuler LA
    Breast Cancer Res; 2017 Jan; 19(1):9. PubMed ID: 28103936
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A phosphorylation code for oestrogen receptor-alpha predicts clinical outcome to endocrine therapy in breast cancer.
    Skliris GP; Nugent ZJ; Rowan BG; Penner CR; Watson PH; Murphy LC
    Endocr Relat Cancer; 2010 Sep; 17(3):589-97. PubMed ID: 20418363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oestrogen receptors alpha and beta show different associations to clinicopathological parameters and their co-expression might predict a better response to endocrine treatment in breast cancer.
    Borgquist S; Holm C; Stendahl M; Anagnostaki L; Landberg G; Jirström K
    J Clin Pathol; 2008 Feb; 61(2):197-203. PubMed ID: 18223096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. KLF17 attenuates estrogen receptor α-mediated signaling by impeding ERα function on chromatin and determines response to endocrine therapy.
    Ali A; Ielciu I; Alkreathy HM; Khan AA
    Biochim Biophys Acta; 2016 Jul; 1859(7):883-95. PubMed ID: 27107895
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interactions between MAP kinase and oestrogen receptor in human breast cancer.
    McGlynn LM; Tovey S; Bartlett JM; Doughty J; Cooke TG; Edwards J
    Eur J Cancer; 2013 Apr; 49(6):1176-86. PubMed ID: 23265704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aurora-A mitotic kinase induces endocrine resistance through down-regulation of ERα expression in initially ERα+ breast cancer cells.
    Opyrchal M; Salisbury JL; Zhang S; McCubrey J; Hawse J; Goetz MP; Lomberk GA; Haddad T; Degnim A; Lange C; Ingle JN; Galanis E; D'Assoro AB
    PLoS One; 2014; 9(5):e96995. PubMed ID: 24816249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IL-1-conferred gene expression pattern in ERα
    Nawas AF; Kanchwala M; Thomas-Jardin SE; Dahl H; Daescu K; Bautista M; Anunobi V; Wong A; Meade R; Mistry R; Ghatwai N; Bayerl F; Xing C; Delk NA
    BMC Cancer; 2020 Jan; 20(1):46. PubMed ID: 31959131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heregulin controls ERα and HER2 signaling in mammospheres of ERα-positive breast cancer cells and interferes with the efficacy of molecular targeted therapy.
    Fukui F; Hayashi SI; Yamaguchi Y
    J Steroid Biochem Mol Biol; 2020 Jul; 201():105698. PubMed ID: 32404282
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The mitotic kinase Aurora--a promotes distant metastases by inducing epithelial-to-mesenchymal transition in ERα(+) breast cancer cells.
    D'Assoro AB; Liu T; Quatraro C; Amato A; Opyrchal M; Leontovich A; Ikeda Y; Ohmine S; Lingle W; Suman V; Ecsedy J; Iankov I; Di Leonardo A; Ayers-Inglers J; Degnim A; Billadeau D; McCubrey J; Ingle J; Salisbury JL; Galanis E
    Oncogene; 2014 Jan; 33(5):599-610. PubMed ID: 23334326
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ERα is a target for butein-induced growth suppression in breast cancer.
    Huang C; Xia X; He J; Liu Y; Shao Z; Hu T; Yu C; Liu X; Xu Q; Liu B; Liu N; Liao Y; Huang H
    Am J Cancer Res; 2020; 10(11):3721-3736. PubMed ID: 33294263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of estrogen receptor alpha protein level and survival function by DBC-1.
    Trauernicht AM; Kim SJ; Kim NH; Boyer TG
    Mol Endocrinol; 2007 Jul; 21(7):1526-36. PubMed ID: 17473282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Receptor Conversion in Distant Breast Cancer Metastases: A Systematic Review and Meta-analysis.
    Schrijver WAME; Suijkerbuijk KPM; van Gils CH; van der Wall E; Moelans CB; van Diest PJ
    J Natl Cancer Inst; 2018 Jun; 110(6):568-580. PubMed ID: 29315431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.